跳至主要内容
临床试验/NCT06286917
NCT06286917进行中(未招募)不适用

Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency

Tampere University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年3月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
试验地点
1
主要终点
Compliance with NIV according to NIV initiation setting in patients with ALS

研究概览

简要总结

This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ALS diagnosed by a neurology and
  • chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS

排除标准

  • impaired cognition to give informed consent to participation
  • contraindication to NIV therapy
  • another severe disease with a prognosis of less than one year
  • ventilation via an artificial airway, tracheostomy

研究组 & 干预措施

NIV initiation in outpatient clinic in patients with ALS

Active Comparator

Starting the NIV at the outpatient clinic

干预措施: NIV initiation in patients with ALS (Other)

NIV initiation in pulmonary ward in patients with ALS

Active Comparator

Starting the NIV in the pulmonary ward

干预措施: NIV initiation in patients with ALS (Other)

结局指标

主要结局

Compliance with NIV according to NIV initiation setting in patients with ALS

时间窗: 5 years

Association between the initiation method and the patients' compliance with the goal of using NIV more than 4 hours per day.

NIV usage hours according to different initiation locations in patients with ALS

时间窗: 5 years

NIV daily usage hours in the 3-month control after initiation (determined over the preceding month)

Decrease in blood carbon dioxide levels in patients with ALS depending on the place of NIV initiation.

时间窗: 5 years

The effectiveness of the treatment on the reduction of blood carbon dioxide pressure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heidi Rantala

Consultant

Tampere University Hospital

研究点 (1)

Loading locations...

相似试验